US Stock MarketDetailed Quotes

MDGSW Medigus C/Wts 23/07/2023(To Pur Ads)Series C

  • 0.0231
  • 0.00000.00%
Trading Jul 19 16:00 ET
0Market Cap0.00P/E (TTM)

About Medigus C/Wts 23/07/2023(To Pur Ads)Series C Company

Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.

Company Profile

Company NameMedigus C/Wts 23/07/2023(To Pur Ads)Series C
CEOMr. Liron Carmel
Securities TypeOrdinary Shares
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Liron Carmel
  • Chief Executive Officer
  • 451.00K
  • Tali Dinar
  • Chief Financial Officer
  • 222.00K
  • Eliyahu Yoresh
  • Chairman of the Board
  • 365.00K
  • Kineret Tzedef
  • Independent Director
  • 87.00K
  • Eli Cohen
  • Independent Director
  • 81.00K
  • Ronen Rosenbloom
  • Independent Director
  • --


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price